Cargando…
Deleted in lymphocytic leukemia 2 (DLEU2): a possible biomarker that holds promise for future diagnosis and treatment of cancer
The mechanism of deleted in lymphocytic leukemia 2 (DLEU2)-long non-coding RNA in tumors has become a major point of interest in recent research related to the occurrence and development of a variety of tumors. Recent studies have shown that the long non-coding RNA DLEU2 (lncRNA-DLEU2) can cause abn...
Autores principales: | Qu, Xue, Cao, Yu-xia, Xing, Yuan-xin, Liu, Qi, Li, Huan-jie, Yang, Wei-hua, Wang, Ban-qin, Han, Shu-yi, Wang, Yun-shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462543/ https://www.ncbi.nlm.nih.gov/pubmed/37095423 http://dx.doi.org/10.1007/s12094-023-03149-x |
Ejemplares similares
-
Genomic instability in a chronic lymphocytic leukemia patient with mono-allelic deletion of the DLEU and RB1 genes
por: Nava-Rodríguez, María Paulina, et al.
Publicado: (2019) -
Therapeutic Implications of Activation of the Host Gene (Dleu2) Promoter for miR-15a/16-1 in Chronic Lymphocytic Leukemia (CLL)
por: Kasar, S, et al.
Publicado: (2013) -
P612: ASSESSMENT OF THE DEVELOPMENT OF B CELL MALIGNANCIES IN A NOVEL MURINE MODEL CARRYING DLEU2 DELETION
por: Ramassone, Alice, et al.
Publicado: (2023) -
Tumor reversion holds promise
por: Telerman, Adam, et al.
Publicado: (2010) -
Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma
por: Shi, Yi, et al.
Publicado: (2021)